Citations to this article
Philippe Lefebvre, … , Sven Francque, Bart Staels
Published July 6, 2017
Citation Information: JCI Insight. 2017;2(13):e92264. https://doi.org/10.1172/jci.insight.92264.
Citation Information: JCI Insight. 2017;2(13):e92264. https://doi.org/10.1172/jci.insight.92264.
Abstract
Nonalcoholic fatty liver disease prevalence is soaring with the obesity pandemic, but the pathogenic mechanisms leading to the progression toward active nonalcoholic steatohepatitis (NASH) and fibrosis, major causes of liver-related death, are poorly defined. To identify key components during the progression toward NASH and fibrosis, we investigated the liver transcriptome in a human cohort of NASH patients. The transition from histologically proven fatty liver to NASH and fibrosis was characterized by gene expression patterns that successively reflected altered functions in metabolism, inflammation, and epithelial-mesenchymal transition. A meta-analysis combining our and public human transcriptomic datasets with murine models of NASH and fibrosis defined a molecular signature characterizing NASH and fibrosis and evidencing abnormal inflammation and extracellular matrix (ECM) homeostasis. Dermatopontin expression was found increased in fibrosis, and reversal of fibrosis after gastric bypass correlated with decreased dermatopontin expression. Functional studies in mice identified an active role for dermatopontin in collagen deposition and fibrosis. PPARα activation lowered dermatopontin expression through a transrepressive mechanism affecting the Klf6/TGFβ1 pathway. Liver fibrotic histological damages are thus characterized by the deregulated expression of a restricted set of inflammation- and ECM-related genes. Among them, dermatopontin may be a valuable target to reverse the hepatic fibrotic process.
Authors
Philippe Lefebvre, Fanny Lalloyer, Eric Baugé, Michal Pawlak, Céline Gheeraert, Hélène Dehondt, Jonathan Vanhoutte, Eloise Woitrain, Nathalie Hennuyer, Claire Mazuy, Marie Bobowski-Gérard, Francesco Paolo Zummo, Bruno Derudas, Ann Driessen, Guy Hubens, Luisa Vonghia, Wilhelmus J. Kwanten, Peter Michielsen, Thomas Vanwolleghem, Jérôme Eeckhoute, An Verrijken, Luc Van Gaal, Sven Francque, Bart Staels
Total citations by year
Citation information
Citations to this article (80)
| Title and authors | Publication | Year |
|---|---|---|
|
Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies
Bourganou MV, Chondrogianni ME, Kyrou I, Flessa CM, Chatzigeorgiou A, Oikonomou E, Lambadiari V, Randeva HS, Kassi E |
International Journal of Molecular Sciences | 2025 |
|
Integrated analysis of differentially expressed genes and miRNA expression profiles in dilated cardiomyopathy
Chen Y, Cai WK, Yu J, Shen M, Zhou JH, Yang SY, Liu W, Lu S, Shi YK, Yang LX |
Heliyon | 2024 |
|
Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model.
Kostadinova R, Ströbel S, Chen L, Fiaschetti-Egli K, Gadient J, Pawlowska A, Petitjean L, Bieri M, Thoma E, Petitjean M |
Scientific Reports | 2024 |
|
Comprehensive meta-analysis reveals distinct gene expression signatures of MASLD progression
Piras IS, DiStefano JK |
Life science alliance | 2024 |
|
Emerging Insights into the Role of BDNF on Health and Disease in Periphery
Ichimura-Shimizu M, Kurrey K, Miyata M, Dezawa T, Tsuneyama K, Kojima M |
Biomolecules | 2024 |
|
Analysis of machine learning based integration to identify the crosslink between inflammation and immune response in non-alcoholic fatty liver disease through bioinformatic analysis
Yu R, Huang Y, Hu X, Chen J |
Heliyon | 2024 |
|
Identification of HTRA1, DPT and MXRA5 as potential biomarkers associated with osteoarthritis progression and immune infiltration
Sun Y, Yang H, Guo J, Du J, Han S, Yang X |
BMC Musculoskeletal Disorders | 2024 |
|
High-Protein Mulberry Leaves Improve Glucose and Lipid Metabolism via Activation of the PI3K/Akt/PPARα/CPT-1 Pathway
Shan Z, Zhang H, He C, An Y, Huang Y, Fu W, Wang M, Du Y, Xie J, Yang Y, Zhao B |
International Journal of Molecular Sciences | 2024 |
|
Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomy
Chen S, Zeng Q, Cai X, Xue J, Yin G, Song P, Tang L, Klein C, Tacke F, Guillot A, Liu H |
International Journal of Biological Sciences | 2024 |
|
Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis.
Das S, Finney AC, Anand SK, Rohilla S, Liu Y, Pandey N, Ghrayeb A, Kumar D, Nunez K, Liu Z, Arias F, Zhao Y, Pearson-Gallion BH, McKinney MP, Richard KSE, Gomez-Vidal JA, Abdullah CS, Cockerham ED, Eniafe J, Yurochko AD, Magdy T, Pattillo CB, Kevil CG, Razani B, Bhuiyan MS, Seeley EH, Galliano GE, Wei B, Tan L, Mahmud I, Surakka I, Garcia-Barrio MT, Lorenzi PL, Gottlieb E, Salido E, Zhang J, Orr AW, Liu W, Diaz-Gavilan M, Chen YE, Dhanesha N, Thevenot PT, Cohen AJ, Yurdagul A Jr, Rom O |
Nature metabolism | 2024 |
|
Tumor-associated neutrophils attenuate the immunosensitivity of hepatocellular carcinoma
Teo JM, Chen Z, Chen W, Tan RJ, Cao Q, Chu Y, Ma D, Chen L, Yu H, Lam KH, Lee TK, Chakarov S, Becher B, Zhang N, Li Z, Ma S, Xue R, Ling GS |
The Journal of Experimental Medicine | 2024 |
|
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease
Raverdy V, Tavaglione F, Chatelain E, Lassailly G, De Vincentis A, Vespasiani-Gentilucci U, Qadri SF, Caiazzo R, Verkindt H, Saponaro C, Kerr-Conte J, Baud G, Marciniak C, Chetboun M, Oukhouya-Daoud N, Blanck S, Vandel J, Olsson L, Chakaroun R, Gnemmi V, Leteurtre E, Lefebvre P, Haas JT, Yki-Järvinen H, Francque S, Staels B, Le Roux CW, Tremaroli V, Mathurin P, Marot G, Romeo S, Pattou F |
Nature Medicine | 2024 |
|
DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP
Ye D, Wang Y, Deng X, Zhou X, Liu D, Zhou B, Zheng W, Wang X, Fang L |
Cell Death and Disease | 2023 |
|
Identification of Key Target Genes and Pathway Analysis in Nonalcoholic Fatty Liver Disease Via Integrated Bioinformatics Analysis
Chen X, Zhang L, Wang Y, Li R, Yang M, Gao L |
2023 | |
|
EMP1 as a Potential Biomarker in Liver Fibrosis: A Bioinformatics Analysis
Chen X, Lv X, Han M, Hu Y, Zheng W, Xue H, Li Z, Li K, Tan W |
Gastroenterology Research and Practice | 2023 |
|
Identification of disease-related genes and construction of a gene co-expression database in non-alcoholic fatty liver disease
Ye H, Sun M, Su M, Chen D, Liu H, Ma Y, Luo W, Li H, Xu F |
Frontiers in Genetics | 2023 |
|
Dysregulated peripheral proteome reveals NASH-specific signatures identifying patient subgroups with distinct liver biology
Stiglund N, Hagström H, Stål P, Cornillet M, Björkström NK |
Frontiers in immunology | 2023 |
|
Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure
Pan Q, Ai W, Chen Y, Kim DM, Shen Z, Yang W, Jiang W, Sun Y, Safe S, Guo S |
Diabetes | 2023 |
|
TRAF2 decreases lipid accumulation in hepatocytes under endoplasmic reticulum stress: TRAF2 increases the ubiquitination of XBP1s
Li S, Li Y, Wang X, Xia Z, Hu R |
Acta Biochimica et Biophysica Sinica | 2023 |
|
GARP on hepatic stellate cells is essential for the development of liver fibrosis
Zhang X, Sharma P, Maschmeyer P, Hu Y, Lou M, Kim J, Fujii H, Unutmaz D, Schwabe RF, Winau F |
Journal of Hepatology | 2023 |
|
A gut microbial metabolite of linoleic acid ameliorates liver fibrosis by inhibiting TGF-β signaling in hepatic stellate cells
Kasahara N, Imi Y, Amano R, Shinohara M, Okada K, Hosokawa Y, Imamori M, Tomimoto C, Kunisawa J, Kishino S, Ogawa J, Ogawa W, Hosooka T |
Scientific Reports | 2023 |
|
Found in Translation – Fibrosis in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Wang S, Friedman SL |
Science Translational Medicine | 2023 |
|
SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH
Cano L, Desquilles L, Ghukasyan G, Angenard G, Landreau C, Corlu A, Clément B, Turlin B, Le Ferrec E, Aninat C, Massart J, Musso O |
2023 | |
|
Chronic metabolic stress drives developmental programs and loss of tissue functions in non-transformed liver that mirror tumor states and stratify survival
Tzouanas CN, Sherman MS, Shay JE, Rubin AJ, Mead BE, Dao TT, Butzlaff T, Mana MD, Kolb KE, Walesky C, Pepe-Mooney BJ, Smith CJ, Prakadan SM, Ramseier ML, Tong EY, Joung J, Chi F, McMahon-Skates T, Winston CL, Jeong WJ, Aney KJ, Chen E, Nissim S, Zhang F, Deshpande V, Lauer GM, Yilmaz ÖH, Goessling W, Shalek AK |
2023 | |
|
Time-of-day-dependent variation of the human liver transcriptome and metabolome is disrupted in MASLD
Johanns M, Haas JT, Raverdy V, Vandel J, Chevalier-Dubois J, Guille L, Derudas B, Legendre B, Caiazzo R, Verkindt H, Gnemmi V, Leteurtre E, Derhourhi M, Bonnefond A, Froguel P, Eeckhoute J, Lassailly G, Mathurin P, Pattou F, Staels B, Lefebvre P |
2023 | |
|
Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway
B Jiang, D Wang, Y Hu, W Li, F Liu, X Zhu, X Li, H Zhang, H Bai, Q Yang, X Yang, J Ben, Q Chen |
Molecular Metabolism | 2022 |
|
Expression of Fibrosis-Related Genes in Liver and Kidney Fibrosis in Comparison to Inflammatory Bowel Diseases
M Jerala, N Hauptman, N Kojc, N Zidar |
Cells | 2022 |
|
Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery
J Boeckmans, A Gatzios, A Heymans, M Rombaut, V Rogiers, J Kock, T Vanhaecke, R Rodrigues |
Cells | 2022 |
|
Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control
M Montgomery, J Bayliss, S Nie, W Nardo, S Keenan, P Miotto, H Karimkhanloo, C Huang, R Schittenhelm, A Don, A Ryan, N Williamson, G Ooi, W Brown, P Burton, B Parker, M Watt |
Nature Communications | 2022 |
|
Adaptation of Oxidative Phosphorylation Machinery Compensates for Hepatic Lipotoxicity in Early Stages of MAFLD
Fahlbusch P, Nikolic A, Hartwig S, Jacob S, Kettel U, Köllmer C, Al-Hasani H, Lehr S, Müller-Wieland D, Knebel B, Kotzka J |
International journal of molecular sciences | 2022 |
|
Molecular signatures of long-term hepatocellular carcinoma risk in non-alcoholic fatty liver disease
Fujiwara N, Kubota N, Crouchet E, Koneru B, Marquez CA, Jajoriya AK, Panda G, Qian T, Zhu S, Goossens N, Wang X, Liang S, Zhong Z, Lewis S, Taouli B, Schwartz ME, Fiel MI, Singal AG, Marrero JA, Fobar AJ, Parikh ND, Raman I, Li QZ, Taguri M, Ono A, Aikata H, Nakahara T, Nakagawa H, Matsushita Y, Tateishi R, Koike K, Kobayashi M, Higashi T, Nakagawa S, Yamashita YI, Beppu T, Baba H, Kumada H, Chayama K, Baumert TF, Hoshida Y |
Science Translational Medicine | 2022 |
|
Systematic Analysis of Long Non-Coding RNA Genes in Nonalcoholic Fatty Liver Disease
Ilieva M, Dao J, Miller HE, Madsen JH, Bishop AJ, Kauppinen S, Uchida S |
Non-Coding RNA | 2022 |
|
Dermatopontin Influences the Development of Obesity-Associated Colon Cancer by Changes in the Expression of Extracellular Matrix Proteins
Catalán V, Domench P, Gómez-Ambrosi J, Ramírez B, Becerril S, Mentxaka A, Rodríguez A, Valentí V, Moncada R, Baixauli J, Silva C, Escalada J, Frühbeck G |
International journal of molecular sciences | 2022 |
|
Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis
Li Y, Yuan SL, Yin JY, Yang K, Zhou XG, Xie W, Wang Q |
World journal of gastrointestinal oncology | 2022 |
|
CD4+ T cell activation and inflammation in NASH-related fibrosis
Zhou Y, Zhang H, Yao Y, Zhang X, Guan Y, Zheng F |
Frontiers in immunology | 2022 |
|
Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease
Sen P, Govaere O, Sinioja T, McGlinchey A, Geng D, Ratziu V, Bugianesi E, Schattenberg JM, Vidal-Puig A, Allison M, Cockell S, Daly AK, Hyötyläinen T, Anstee QM, Orešič M |
iScience | 2022 |
|
Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis.
Bobowski-Gerard M, Boulet C, Zummo FP, Dubois-Chevalier J, Gheeraert C, Bou Saleh M, Strub JM, Farce A, Ploton M, Guille L, Vandel J, Bongiovanni A, Very N, Woitrain E, Deprince A, Lalloyer F, Bauge E, Ferri L, Ntandja-Wandji LC, Cotte AK, Grangette C, Vallez E, Cianférani S, Raverdy V, Caiazzo R, Gnemmi V, Leteurtre E, Pourcet B, Paumelle R, Ravnskjaer K, Lassailly G, Haas JT, Mathurin P, Pattou F, Dubuquoy L, Staels B, Lefebvre P, Eeckhoute J |
Nature Communications | 2022 |
|
Folic acid depletion as well as oversupplementation helps in the progression of hepatocarcinogenesis in HepG2 cells
Sharma R, Ali T, Kaur J |
Scientific Reports | 2022 |
|
Intrahepatic paracrine signaling by CLCF1 ameliorates diet-induced NASH in mice
Liu T, Wang Q, Zhou L, Zhang P, Mi L, Qiu X, Chen Z, Kuang H, Li S, Lin JD |
Hepatology | 2022 |
|
Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism
Deprince A, Hennuyer N, Kooijman S, Pronk AC, Baugé E, Lienard V, Verrijken A, Dirinck E, Vonghia L, Woitrain E, Kloosterhuis NJ, Marez E, Jacquemain P, Wolters JC, Lalloyer F, Eberlé D, Quemener S, Vallez E, Tailleux A, Kouach M, Goossens J, Raverdy V, Derudas B, Kuivenhoven JA, Croyal M, van de Sluis B, Francque S, Pattou F, Rensen PC, Staels B, Haas JT |
Hepatology | 2022 |
|
Reprogramming of Hepatic Metabolism and Liver Microenvironment in Nonalcoholic Steatohepatitis
Rui L, Lin JD |
Annual Review of Nutrition | 2022 |
|
A human multi-lineage hepatic organoid model for liver fibrosis
Y Guan, A Enejder, M Wang, Z Fang, L Cui, SY Chen, J Wang, Y Tan, M Wu, X Chen, PK Johansson, I Osman, K Kunimoto, P Russo, SC Heilshorn, G Peltz |
Nature Communications | 2021 |
|
Multi-omics analyses of early liver injury reveals cell-type-specific transcriptional and epigenomic shift
M Migdał, E Tralle, KA Nahia, Ł Bugajski, KZ Kędzierska, F Garbicz, K Piwocka, CL Winata, M Pawlak |
BMC Genomics | 2021 |
|
Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery
F Chen, Y Zhou, Z Wu, Y Li, W Zhou, Y Wang |
Frontiers in Endocrinology | 2021 |
|
Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies
JF Català-Senent, MR Hidalgo, M Berenguer, G Parthasarathy, H Malhi, P Malmierca-Merlo, M de la Iglesia-Vayá, F García-García |
Biology of sex differences | 2021 |
|
Bariatric Surgery Affects Plasma Levels of Alanine Aminotransferase Independent of Weight Loss: A Registry-Based Study
S Azulai, R Grinbaum, N Beglaibter, SM Eldar, M Rubin, S Carmi, RB Schyr, O Romano-Zelekha, D Ben-Zvi |
Journal of Clinical Medicine | 2021 |
|
Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis
J Yu, C Zhu, X Wang, KJ Kim, A Bartolome, P Dongiovanni, KP Yates, L Valenti, M Carrer, T Sadowski, L Qiang, I Tabas, JE Lavine, UB Pajvani |
Science Translational Medicine | 2021 |
|
Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD
L Pantano, G Agyapong, Y Shen, Z Zhuo, F Fernandez-Albert, W Rust, D Knebel, J Hill, CM Boustany-Kari, JF Doerner, JF Rippmann, RT Chung, SJ Sui, E Simon, KE Corey |
Scientific Reports | 2021 |
|
The Protective Effects of Live and Pasteurized Akkermansia muciniphila and Its Extracellular Vesicles against HFD/CCl4-Induced Liver Injury
SK Raftar, F Ashrafian, A Yadegar, A Lari, HR Moradi, A Shahriary, M Azimirad, H Alavifard, Z Mohsenifar, M Davari, F Vaziri, A Moshiri, SD Siadat, MR Zali, JM Auchtung |
Microbiology spectrum | 2021 |
|
Clinical Significance of HSPD1/MMP14/ITGB1/miR-6881-5P/Lnc-SPARCL1-1:2 RNA Panel in NAFLD/NASH Diagnosis: Egyptian Pilot Study
R Albadawy, SH Agwa, E Khairy, M Saad, NE Touchy, M Othman, M Matboli |
Biomedicines | 2021 |
|
Hepatic sexual dimorphism — implications for non-alcoholic fatty liver disease
P Lefebvre, B Staels |
Nature Reviews Endocrinology | 2021 |
|
A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease
Y Song, J Zhang, H Wang, D Guo, C Yuan, B Liu, H Zhong, D Li, Y Li |
Adipocyte | 2021 |
|
Identification of the distinctive role of DPT in dilated cardiomyopathy: a study based on bulk and single-cell transcriptomic analysis
Y Lu, Q Wu, J Liao, S Zhang, K Lu, S Yang, Y Wu, Q Dong, J Yuan, N Zhao, Y Du |
Annals of translational medicine | 2021 |
|
Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
K Day, LA Seale, RM Graham, BR Cardoso |
Frontiers in Nutrition | 2021 |
|
Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome
O Rom, Y Liu, Z Liu, Y Zhao, J Wu, A Ghrayeb, L Villacorta, Y Fan, L Chang, L Wang, C Liu, D Yang, J Song, JC Rech, Y Guo, H Wang, G Zhao, W Liang, Y Koike, H Lu, T Koike, T Hayek, S Pennathur, , B Wen, D Sun, MT Garcia-Barrio, M Aviram, E Gottlieb, I Mor, W Liu, J Zhang, YE Chen |
Science Translational Medicine | 2020 |
|
Bile acid composition regulates GPR119-dependent intestinal lipid sensing and food intake regulation in mice
S Higuchi, TR Ahmad, DA Argueta, PA Perez, C Zhao, GJ Schwartz, NV DiPatrizio, RA Haeusler |
Gut | 2020 |
|
Prediction of severity and subtype of fibrosing disease using model informed by inflammation and extracellular matrix gene index
AM Cheikhi, ZI Johnson, DR Julian, S Wheeler, C Feghali-Bostwick, YP Conley, J Lyons-Weiler, CC Yates, M Wu |
PloS one | 2020 |
|
The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
N Perakakis, K Stefanakis, CS Mantzoros |
Metabolism | 2020 |
|
Transcriptional Dynamics of Hepatic Sinusoid‐Associated Cells After Liver Injury
MK Terkelsen, SM Bendixen, D Hansen, EA Scott, AF Moeller, R Nielsen, S Mandrup, A Schlosser, TL Andersen, GL Sorensen, A Krag, KN Natarajan, S Detlefsen, H Dimke, K Ravnskjaer |
Hepatology | 2020 |
|
Dermatopontin, A Novel Adipokine Promoting Adipose Tissue Extracellular Matrix Remodelling and Inflammation in Obesity
X Unamuno, J Gómez-Ambrosi, B Ramírez, A Rodríguez, S Becerril, V Valentí, R Moncada, C Silva, J Salvador, G Frühbeck, V Catalán |
Journal of Clinical Medicine | 2020 |
|
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker
GA Baselli, P Dongiovanni, R Rametta, M Meroni, S Pelusi, M Maggioni, S Badiali, P Pingitore, S Maurotti, T Montalcini, AE Taliento, D Prati, G Rossi, AL Fracanzani, RM Mancina, S Romeo, L Valenti |
Gut | 2020 |
|
Multi-Omics Integration Highlights the Role of Ubiquitination in CCl4-Induced Liver Fibrosis
M Mercado-Gómez, F Lopitz-Otsoa, M Azkargorta, M Serrano-Maciá, S Lachiondo-Ortega, N Goikoetxea-Usandizaga, R Rodríguez-Agudo, D Fernández-Ramos, M Bizkarguenaga, VG Juan, B Lectez, K Aloria, JM Arizmendi, J Simon, C Alonso, JJ Lozano, MA Avila, JM Banales, JJ Marin, N Beraza, JM Mato, F Elortza, R Barrio, JD Sutherland, U Mayor, ML Martínez-Chantar, TC Delgado |
International journal of molecular sciences | 2020 |
|
Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH)
J Vandel, J DuboisChevalier, C Gheeraert, B Derudas, V Raverdy, D Thuillier, L Gaal, S Francque, F Pattou, B Staels, J Eeckhoute, P Lefebvre |
Hepatology | 2020 |
|
QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis
K You, L Wang, CH Chou, K Liu, T Nakata, A Jaiswal, J Yao, A Lefkovith, A Omar, JG Perrigoue, JE Towne, A Regev, DB Graham, RJ Xavier |
Science | 2020 |
|
hnRNPU/TrkB defines a chromatin accessibility checkpoint for liver injury and NASH pathogenesis
J Xiong, T Liu, L Mi, H Kuang, X Xiong, Z Chen, S Li, JD Lin |
Hepatology | 2019 |
|
The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
MA Herck, J Weyler, WJ Kwanten, EL Dirinck, BY Winter, SM Francque, L Vonghia |
Frontiers in immunology | 2019 |
|
Transcriptional regulation of Hepatic Stellate Cell activation in NASH
AB Marcher, SM Bendixen, MK Terkelsen, SS Hohmann, MH Hansen, BD Larsen, S Mandrup, H Dimke, S Detlefsen, K Ravnskjaer |
Scientific Reports | 2019 |
|
Multi-omics insights into functional alterations of the liver in insulin-deficient diabetes mellitus
M Backman, F Flenkenthaler, A Blutke, M Dahlhoff, E Ländström, S Renner, J Philippou-Massier, S Krebs, B Rathkolb, C Prehn, M Grzybek, Ü Coskun, M Rothe, J Adamski, MH de Angelis, R Wanke, T Fröhlich, GJ Arnold, H Blum, E Wolf |
Molecular Metabolism | 2019 |
|
Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα
N Liang, A Damdimopoulos, S Goñi, Z Huang, LL Vedin, T Jakobsson, M Giudici, O Ahmed, M Pedrelli, S Barilla, F Alzaid, A Mendoza, T Schröder, R Kuiper, P Parini, A Hollenberg, P Lefebvre, S Francque, LV Gaal, B Staels, N Venteclef, E Treuter, R Fan |
Nature Communications | 2019 |
|
Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan
JG Park, JS Mok, YI Han, TS Park, KW Kang, CS Choi, HD Park, J Park |
Scientific Reports | 2019 |
|
Gene Expression Predicts Histological Severity and Reveals Distinct Molecular Profiles of Nonalcoholic Fatty Liver Disease
SA Hoang, A Oseini, RE Feaver, BK Cole, A Asgharpour, R Vincent, M Siddiqui, MJ Lawson, NC Day, JM Taylor, BR Wamhoff, F Mirshahi, MJ Contos, M Idowu, AJ Sanyal |
Scientific Reports | 2019 |
|
Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution
JT Haas, L Vonghia, DA Mogilenko, A Verrijken, O Molendi-Coste, S Fleury, A Deprince, A Nikitin, E Woitrain, L Ducrocq-Geoffroy, S Pic, B Derudas, H Dehondt, C Gheeraert, LV Gaal, A Driessen, P Lefebvre, B Staels, S Francque, D Dombrowicz |
2019 | |
|
Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes
Divya Ramnath, Katharine Irvine, Samuel W Lukowski, Leigh Horsfall, Zhixuan Loh, Andrew D Clouston, Preya J Patel, Kevin Fagan, Abishek Iyer, Guy Lampe, Jennifer Stow, Kate Schroder, David P. Fairlie, Joseph Powell, Elizabeth E Powell, Matthew Sweet |
JCI Insight | 2018 |
|
Krüppel-Like Factors in Metabolic Homeostasis and Cardiometabolic Disease
Y Oishi, I Manabe |
Frontiers in Cardiovascular Medicine | 2018 |
|
Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi
X Xiong, Q Wang, S Wang, J Zhang, T Liu, L Guo, Y Yu, JD Lin |
Molecular Metabolism | 2018 |
|
Concomitant PPARα and FXR Activation as a Putative Mechanism of NASH Improvement after Gastric Bypass Surgery: a GEO Datasets Analysis
GS Mazzini, J Khoraki, M Dozmorov, MG Browning, D Wijesinghe, L Wolfe, RR Gurski, GM Campos |
Journal of Gastrointestinal Surgery | 2018 |
|
Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes
GS Gerhard, C Legendre, CD Still, X Chu, A Petrick, JK DiStefano |
Journal of the Endocrine Society | 2018 |
|
Key Inflammatory Processes in Human NASH Are Reflected in Ldlr−/−.Leiden Mice: A Translational Gene Profiling Study
MC Morrison, R Kleemann, A van Koppen, R Hanemaaijer, L Verschuren |
Frontiers in physiology | 2018 |
|
Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling
JQ Liang, N Teoh, L Xu, S Pok, X Li, ES Chu, J Chiu, L Dong, E Arfianti, WG Haigh, MM Yeh, GN Ioannou, JJ Sung, G Farrell, J Yu |
Nature Communications | 2018 |
|
Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease
N Goossens, F Jornayvaz |
Nutrients | 2017 |
